Active	Status	Sponsor type	Region	Phase	Filter
3 Active 4 Inactive 7 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

2 Trials

Active Trials   Industry lead sponsorIndustry collaborator

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Bhutani, Tina
ADapt, NCT05369403: A Study of Lebrikizumab (LY3650150) in Adult and Adolescent Participants With Moderate-to-Severe Atopic Dermatitis Previously Treated With Dupilumab	Active, not recruiting	3	120	US	Lebrikizumab, LY3650150, DRM06	Eli Lilly and Company	Atopic Dermatitis	01/24	02/25
DREAMS-PSO, NCT05102474: Dermatologic Research Evaluation and Monitoring of Sleep in Moderate-to-Severe Psoriasis	Recruiting	N/A	24	US	Polysomnography (PSG)	University of California, San Francisco, Novartis Pharmaceuticals, National Psoriasis Foundation	Psoriasis Vulgaris	05/24	05/24